Dimethyl fumarate (DMF), a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibitor, which has been shown to treat autoimmune diseases, was found to promote oxPPP by increasing G6PD expression in tumor cells. Here, GAPDH is linked to autoimmune disease.